The FDA said Stryker had marketed devices without approval, and pointed out that the device manufacturer failed to notify the regulatory body of a product recall, according to the report. Stryker submitted a plan to correct the quality and recall issues.
More Articles on Devices:
13 Recent Device Company Executive & Leadership Changes
NLT Spine Opens US Subsidiary
Alphatec Solus Fusion Device Receives FDA 510(k) Clearance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.